Philip S. Low

Next Generation Targeted Therapeutics

Lab Members

Dr. Philip Low

Philip Low

Dr. Philip S. Low is the Presidential Scholar for Drug Discovery and the Ralph C. Corley Distinguished Professor of Chemistry. Dr. Low has spent over 50 years exploring:

  1. targeted therapeutic and imaging agents for multiple human diseases (including cancer, autoimmune, infectious, inherited, and inflammatory diseases),
  2. the structure, function, and pathologies of the erythrocyte membrane, and
  3. signal transduction across plant cell membranes. 

He has published over 500 scientific articles and has over 360 US patents/patents pending. Eight drugs stemming from his research are undergoing human clinical trials and seven companies (Endocyte Inc., OnTarget Laboratories Inc., Quince Therapeutics Inc., Umoja Biopharma, Eradivir Inc., Morphimmune Inc., and ErythroCure Inc.) have been founded to commercialize these discoveries. Dr. Low received his B.S. in Chemistry from BYU (1971) and his Ph.D. in Biochemistry from UCSD (1975).





Group Members

Visiting Scholars




Graduate Students


The Low lab group 

The Low Lab group in the summer.